# Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery

> clinical trial · VERIFIED · 2026-07-23

Status: ACTIVE_NOT_RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Anal Melanoma

- Company: National Cancer Institute (NCI)
- Sector: Anal Melanoma
- Primary source: https://clinicaltrials.gov/study/NCT05111574

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.